Sort
23,748 grants matching “melanoma”
Tumor infiltrating lymphocyte therapy for human papillomavirus-positive cancers
$1,056,174Christian Hinrichs · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Computational Molecular Pathology Research for Cancer Diagnostics and Biomarkers
$1,055,726Robert Simpson · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Pilot Project Program
$1,054,429Raymond E Samuel · Hampton University · U54 · FY2017 · MD
Collaborative Protein Technology Resource - Nano-Scale Protein Analysis Section
$1,053,823Noemi Kedei · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Bioinformatics
$1,053,177Leping Li · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
QBS10072S for the Treatment of Brain Metastatic Triple-Negative Breast Cancer
$1,053,136Gordon M Ringold · Quadriga Biosciences, Inc. · R44 · FY2021 · CA
MELANOMA RESEARCH PROGRAM
$1,052,998The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2022 · Department of the Army
Imaging cellular assemblies with three-dimensional electron microscopy
$1,052,305Sriram Subramaniam · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Structural Studies of Pattern Recognition Receptors
$1,052,184Tsan Xiao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
The role of DNA damage and repair at telomeres
$1,052,015Yie Liu · National Institute On Aging · ZIA · FY2015 · AG
Immune Escape in Human Cancer: Mechanisms and Therapeutic Implications
$1,050,724Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P01 · FY2010 · CA
Diagnostic Nodal Staging with Nuclear and NIR Molecular Optical Imaging
$1,050,000Eva M Sevick-Muraca · University Of Texas Hlth Sci Ctr Houston · U54 · FY2008 · CA
A Novel Microbiome-Based Immune-Modulator that Potentiates Cancer Checkpoint Therapy
$1,049,717Gary Fanger · Rise Therapeutics, Llc · R44 · FY2022 · CA
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
$1,048,779Harold John Burstein · Dana-Farber Cancer Inst · UG1 · FY2025 · CA
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
$1,048,778Harold John Burstein · Dana-Farber Cancer Inst · UG1 · FY2024 · CA
Clinical Trials of Immunotherapies for Childhood Cancer
$1,047,388Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Structure, mechanism, and pharmacology of BRAF and its partners in the RAS/RAF/MAP kinase pathway
$1,046,640Michael J Eck · Dana-Farber Cancer Inst · R35 · FY2022 · CA
Structure, mechanism, and pharmacology of BRAF and its partners in the RAS/RAF/MAP kinase pathway
$1,046,639Michael J Eck · Dana-Farber Cancer Inst · R35 · FY2023 · CA
Developing Immune Based Therapies
$1,045,977Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Determining the Fate of Transmembrane Proteins
$1,045,410Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
CANCER AND LEUKEMIA GROUP B CCOP RESEARCH BASE
$1,043,494University Of Chicago · U10 · FY2000 · CA
Determining the Fate of Transmembrane Proteins
$1,043,252Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Vaccine and immunotherapy strategies for cancer and viruses causing cancer
$1,042,696Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
MELANOMA RESEARCH PROGRAM TEAM SCIENCE AWARD
$1,041,595Regents Of The University Of California, San Francisco, The · · FY2025 · Defense Health Agency
Immune checkpoint inhibitors and accelerated coronary atherosclerosis
$1,041,129Tomas G Neilan · Massachusetts General Hospital · R01 · FY2022 · HL